CERDELGA: payments to doctors
Payments that named CERDELGA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $64.1M
- Providers
- 2,426
- Transactions
- 4,462
- Average per transaction
- $14,355
The per-transaction average — $14,355 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,426 providers the average total is $26,402, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi | $63,963,989 | 99.9% |
| Sanofi-aventis U.S. LLC | $73,603 | 0.1% |
| Sanofi US Services Inc. | $13,300 | 0.0% |